TCT-835 Validation of PARIS Risk Scores in Patients Treated With Everolimus-Eluting Stents for Left Main Coronary Artery Disease: Analysis From the EXCEL Trial

Sabato Sorrentino; Bimmer E. Claessen; Roxana Mehran; David E. Kandzari; Marie‐Claude Morice; Martin B. Leon; Bernard J. Gersh; Ori Ben‐Yehuda; Björn Redfors; Ovidiu Dressler; Stuart Pocock; A. Pieter Kappetein; Joseph F. Sabik; Patrick W. Serruys; Gregg W. Stone

doi:10.1016/j.jacc.2018.08.2078

Related publications

Article2018

TCT-1 Optimal Duration of Dual Antiplatelet Therapy After Left Main Coronary Stenting With Everolimus-Eluting Stents: Analysis From the EXCEL Trial

Sorin J. Brener, Patrick W. Serruys, Martin B. Leon, Marie‐Claude Morice, David E. Kandzari, Roxana Mehran, A. Pieter Kappetein, Joseph F. Sabik, Yangbo Liu, Ovidiu Dressler, Ori Ben‐Yehuda, Gregg W. Stone

Journal of the American College of Cardiology

Article2017

TCT-178 Everolimus-Eluting Stents versus Coronary Artery Bypass Graft Surgery for Left Main Coronary Artery Disease in Patients with and without Chronic Kidney Disease

Gennaro Giustino, Joseph F. Sabik, Björn Redfors, Milan Milojevic, Patrick W. Serruys, David E. Kandzari, Marie‐Claude Morice, Anthony Gershlick, Philippe Généreux, Ovidiu Dressler, Zixuan Zhang, Roxana Mehran, A. Pieter Kappetein, Gregg W. Stone

Journal of the American College of Cardiology

Article2017

TCT-825 Outcomes of Patients With and Without Hyperlipidemia Undergoing Revascularization for Left Main Coronary Artery Disease: Analysis from the EXCEL Trial

Shmuel Chen, Björn Redfors, Yangbo Liu, Mathias Vrolix, Carlos Macaya, Ori Ben‐Yehuda, A. Pieter Kappetein, Joseph F. Sabik, Patrick W. Serruys, Gregg W. Stone

Journal of the American College of Cardiology

Article2017

TREATMENT OF LEFT MAIN CORONARY ARTERY DISEASE IN PATIENTS WITH DIABETES: 3-YEAR OUTCOMES COMPARING CABG AND PCI WITH EVEROLIMUS-ELUTING STENTS FROM THE EXCEL STUDY

A. Pieter Kappetein, Milan Milojevic, Patrick W. Serruys, Joseph F. Sabik, Stuart J. Head, David Kandzari, Eric Schampaert, David Taggart, Ferenc Horkay, Kovacs Imre Laszlo, Samer Mansour, Adrian Banning, Manel Sabaté, Andrezj Bochenek, José Luís Pomar, Nicholas Lembo, Nicolas Noiseux, John D. Puskas, Ioanna Kosmidou, Roxana Mehran, Ori Ben‐Yehuda,

Article2018

TCT-36 The Impact of Guideline-Directed Medical Therapy after Revascularization in Patients With Left Main Coronary Artery Disease: Analysis From the EXCEL Trial

R. Jay Widmer, Bernard J. Gersh, Patrick W. Serruys, John D. Puskas, Ori Ben‐Yehuda, David P. Taggart, Marie‐Claude Morice, Nicholas Lembo, William Brown, Adrian Banning, Yiran Zhang, Ovidiu Dressler, A. Pieter Kappetein, Joseph F. Sabik, Gregg W. Stone

Journal of the American College of Cardiology

TCT-835 Validation of PARIS Risk Scores in Patients Treated With Everolimus-Eluting Stents for Left Main Coronary Artery Disease: Analysis From the EXCEL Trial

Abstract

Discussion(0)

Related publications

TCT-1 Optimal Duration of Dual Antiplatelet Therapy After Left Main Coronary Stenting With Everolimus-Eluting Stents: Analysis From the EXCEL Trial

TCT-178 Everolimus-Eluting Stents versus Coronary Artery Bypass Graft Surgery for Left Main Coronary Artery Disease in Patients with and without Chronic Kidney Disease

TCT-825 Outcomes of Patients With and Without Hyperlipidemia Undergoing Revascularization for Left Main Coronary Artery Disease: Analysis from the EXCEL Trial

TREATMENT OF LEFT MAIN CORONARY ARTERY DISEASE IN PATIENTS WITH DIABETES: 3-YEAR OUTCOMES COMPARING CABG AND PCI WITH EVEROLIMUS-ELUTING STENTS FROM THE EXCEL STUDY

TCT-36 The Impact of Guideline-Directed Medical Therapy after Revascularization in Patients With Left Main Coronary Artery Disease: Analysis From the EXCEL Trial